Canada· CA-DIN-02324989
CLEARLAX
A macrogol product containing polyethylene glycol 3350, registered in Canada by PERRIGO INTERNATIONAL. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Macrogol is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AD15 (macrogol), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Macrogol · ATC A06AD15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of macrogol costs, country by country.
Normalised to the WHO defined daily dose (10 g), the median price runs from $0.083 in Finland to $0.66 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Macrogol · price per daily dose (10 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.66
- FI Finland$0.083
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- POLYETHYLENE GLYCOL 3350
- Manufacturer
- PERRIGO INTERNATIONAL
- Country
- Canada (CA)
- ATC code
- A06AD15
- ATC class
- Macrogol
- Defined daily dose
- 10 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macrogol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States365 WHOLE FOODS MARKET Polyethylene Glycol 3350Whole Foods Market, Inc.
- United KingdomCosmoCol Half oral powder 6.9g sachetsStirling Anglian Pharmaceuticals Ltd
- BelgiumColopegBayer
- FranceMACROGOL 3350 MAYOLY SPINDLER 8,5 g, poudre pour solution buvable en sachetLABORATOIRES MAYOLY SPINDLER
- FinlandTransipegBayer Oy
- GermanyMacrogol AdgcZentiva Pharma Gmbh
- IrelandTransisoft 8.5 g powder for oral solution in sachetLaboratoires Mayoly Spindler
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Transisoft
- Germany · Transisoft
- France · Transipeg, Transipeglib
- United Kingdom (Northern Ireland) · Transisoft
- Ireland · Transisoft
- Italy · Transisoft
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3e20381e-78f2-4827-b97f-0dfc6c421c49 GET /v1/drugs/3e20381e-78f2-4827-b97f-0dfc6c421c49?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02324989",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A06AD15",
"schedule": [
"OTC"
],
"drug_code": "81040",
"strengths": [
"100 %"
],
"ahfs_class": null,
"substances": [
"POLYETHYLENE GLYCOL 3350"
],
"product_categorization": null
}See everything about macrogol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.